Abstract. The problem of understanding the mechanisms of differentiation, activation, and interconversion of phenotypes of CD8 + T cells is one of crucial importance in cancer therapy, owing to both the anti-tumor efficacy of CD8 + T cells as well as the severe toxicity that results from excess expansion of this population. Several opposing theories exist which describe potential pathways for the development of the CD8 + T cell repertoire; however, the accuracy of each remains controversial.
Introduction and Background
The importance of understanding T cell differentiation has been recognized, not only in the basic sciences, but also in translation and medical sciences, particularly by those interested in the development and optimization of immunologically based therapies for the treatment of cancers and autoimmune diseases. The success of these therapies relies on precise optimization of the anti-tumor immune response, at the crux of which is CD8 + T cell activation and differentiation. Specifically, upon activation by antigen presenting cells, naïve (antigen-inexperienced) CD8 + T (T N ) cells give rise to progeny which have both effector and memory phenotypes. Effector (T E ) cells reside primarily in peripheral tissues and are characterized by having high cytotoxicity and decreased longevity. Memory (T M ) cells exhibit stem-cell-like longevity and are further divided into two subtypes, central memory (T CM ) cells, which reside primarily in lymphoid tissue and have limited cytoxicity, and effector memory (T EM ) cells, which reside primarily in peripheral tissues and have intermediate cytotoxicity [1, 2, 3, 4, 5] . Due in part to variation in classification procedures between laboratories, the paths by which these populations interconvert have become the subject of much "chicken or the egg" type debate [1, 2, 6, 7, 8, 9] .
Presently, the debate centers predominantly around four models for CD8 + T cell activation and differentiation: (1) the Linear or Uniform Potential Model, in which T cells differentiate in the order T N → T E → T M , (2) the Progressive or Decreasing Potential Model, in which T cells differentiate T N → T CM → T EM → T E , (3) the Signal Strength or Fixed Lineage Model, in which T N cells differentiate either to T E cells, in the case of high antigen signal, or to T M cells in the case of low antigen signal, and are thereafter restricted respectively to the effector or memory phenotype, and (4) the Asymmetric Division Model, in which T N cells give rise to two distinct daughter cells, one with a greater effector potential and one with a greater memory potential [2] .
Several major hurdles preclude a straightforward understanding of this process, not least of which is ambiguity in classification of T cell subtypes. Standard procedures for identifying T cell populations rely on flow cytometry to measure concentrations of surface markers on individual cells. From this output, cells are sorted by "high" or "low" expression levels of particular surface markers, and classified based on the combinations of these markers they express. Discrepancy in classification thus arises due to (a) subjectively defined boundaries used to delimit "high" or "low" expression levels, which can lead to large discrepancies in measurement when subpopulations are not clearly delineated, as is known to be the case especially in the early immune response [10] , and (b) variation in the combinations of markers used to classify cells, which can result in non-trivial overlap of populations identified as discrepant phenotypes. For example, while T N cells are frequently sorted as CD62L + CD44L − , under certain conditions, T M differentiation can be halted, resulting in the formation of a CD62L + CD44L − T stem cell memory (T SCM ) population, which can be distinguished from the T N population by their expression of CD95 (as well as CXCR3, IL-2Rβ , or LFA-1) [4] . However, cells are not always gated on these particular surface markers, and hence, CD62L + CD44L − CD95 + memory T cells are often inadvertently classified as T N cells. Table 1 provides a summary of surface marker profiles characteristic of T N cells as well as four additional phenotypes to which T N cells are known to differentiate through one mechanism or another: T CM , T EM , early effector (T EE ), and short-lived effector (T SLE ) cells. We remark that while the expression profiles in Table 1 do not represent an exhaustive list of possible phenotypes (as this would require an encoding with a dimension equivalent to the number of known surface markers), the expression profiles listed are sufficient to fully distinguish the populations considered. We further remark that various intermediates are indeed known to exist, which will not be considered here, including, at least, T SCM cells, mentioned above, and also intermediate memory T IM [11] . 
Restricting our focus, however, to the subtypes characterized in Table 1 , there exist 24,010 possible combinations of subtype conversion pathways which satisfy the following conditions: (1) the T N subtype has no inward-directed paths (based on the widely agreed upon view that activated T cells do not revert to a naïve phenotype after sufficient encounters with antigen), and (2) the remaining four subtypes each have zero (corresponding to terminal differentiation), one (corresponding to symmetric division), or two (corresponding asymmetric division), outgoing paths. A schematic representation of the possible pathways is shown in Figure 1 (left) . In this review we consider the possibility of existence of a subset of these pathways which remain consistent with all each of the experimental studies reviewed.
The aim of the remainder of our discussion is to establish the possibility of consistency of the predominant biological data presented in support of opposing views by considering the existence of a subset of these pathways which cannot be ruled inconsistent with the literature. We contend that our inclusion of only a subset of possible T cell phenotypes is justifiable given that (a) the existence of non-terminal phenotypes does not preclude identification of interconversion pathways between phenotypes, and (b) the existence of unidentified terminal phenotypes corresponds to irreversible loss of T cells from the total subset of populations considered, which is already an inherent possibility due to the potential for loss of a paricular lineage upon cell death.
Review of existing biological data.

Change et al., 2007
We first consider the 2007 Chang et al. study [3] in which T cells were sorted via flow cytometry and directly visualized using confocal microscopy. In this study, labeled, naïve T cells were stained with carboxyfluorescein diacetate succinimidyl ester (CFSE) and adoptively transfered into wild-type mice infected with Listeria monocytogenes. Subsequently, cells were sorted by relative concentrations of CFSE to identify activated T cells undergoing or having undergone their first division. Polarization of surface markers was observed in greater than 90% of premitotic cells, this polarization was identified to be dependent on the location of the immune synapse, and the proximal and distal daughter cells which were produced after first division were identified to be CD62L − CD44 + GrzB + IL-7Rα − and CD62L + CD44 − GrzB − IL-7Rα + . Thus, the phenotype of the distal daughter is consistent with that of a T CM cell, and the proximal daughter cell phenotype is consistent with either T EE or T SLE cells. Further, because a cell which expresses no KLGR-1 must first express intermediate levels of KLRG-1 before expressing high levels, by necessity of the intermediate value, it is natural to conclude that the proximal daughter arising from the first division after activation of a naïve T cell is most appropriately classified as a T EE cell (this of course is consistent with the naming convention adopted throughout the field). The possible differentiation pathways which satisfy these conditions are now reduced to those shown in Figure 1 (left center), where solid lines denote pathways known to exist, and red lines denote pathways known to rely on activation by antigen presenting cells.
. Schematic representations of (left) all possible paths for interconversion of T cell phenotypes assuming initial activation of T N cells is irreversible, (left center) pathways consistent with results from [3] , (right center) pathways with [3] and [10] , and (right) pathways consistent with [3, 10, 11, 12] . Solid lines represent confirmed existence of pathways, dotted lines represent pathways not contradicted. Red lines represent pathways along which cells progress upon activation by antigen presenting cells. Blue lines represent pathways along which cells are proposed to progress due to antigen concentration and inflammatory signals which may be independent of immune synapse formation.
Sarkar et al., 2008
We next consider a 2008 study by Sarkar et al. [10] in which both KLRG-1 − and KLRG-1 + cells were transferred to donor mice. In the former case, almost 20% of the donor cells survived 40 days after transfer, whereas in the latter case less than 2% of donor cells persisted. We note that in this study in particular, a large percentage of cells exists near the boundary distinguishing KLRG-1 + and KLRG-1 − . This indicates that cells expressing high amounts of KLRG-1, namely T EE cells, are likely a terminally differentiated population.
Plumlee et al., 2015
Further, a 2015 study by Plumlee et al. [12] in which a KLRG-1 − CD127 − population, identified as T EE cells, were purified from virally infected donor mice and transferred to recipient mice which either were or were not previously infected. The recovered donor cells consisted of both KLRG-1 + CD127 − cells (T SLE ), and KLRG-1 − CD127 + cells. However, the number of each KLRG-1 + CD127 − recoverd from virally infected recipients was significantly greater than the number recovered from uninfected recipients. Further, the KLRG-1 produced in recovered populations was greater than Combining the information from these two studies we conclude that T EE cells can give rise to either T M cells or T SLE cells, and that T SLE cells are likely terminally differentiated, bring us to the schematic represented in Figure 1 (right center). The blue line here is used denote differentiation pathways not known to necessary be linked to encounters with antigen presenting cells.
Unsoeld et al., 2005
We lastly consider a straightforward study published by Unsoeld et al. in 2005 in which labeled T cells from lymphocytic choriomeningitis virus (LCMV) infected mice were sorted via flow cytometry for CD62L + CCR7 + expression, a phenotype consistent with T CM cells, purified, and transferred into B6 mice which were subsequently infected with LCMV. Following the infection, labeled donor T cells were sorted and identified to consist of both CD62L + CCR7 + and CD62L − CCR7 − cells, which definitively establishes the existence of a path from T CM cells to T EM cells. Considering this information together with the fact that T CM cells reside in the lymph nodes much like T N cells, and are able to undergo subsequent activation by dendritic cells, we may guess that T CM cells also undergo asymmetric division upon activation. We remark that, to our knowledge, while this has not been proven, it also has not been disproven. This may be a result of (a) difficulty in distinguishing cells which have undergone two division linked activations and cells which have undergoone one division linked activation and one homeostatic division, and (b) a smaller absolute difference in concentrations of surface markers between T EM and T EE cells than between T CM and T EE cells makes a definitive assessment of asymmetric division more difficult to obtain. Combining this information with that from previous studies, we arrive at the schematic presented in Figure 1 (left).
